FMP
NASDAQ
0.0795 USD
0.0066 (8.3%)
Ms. Lisa A. Conte
Healthcare
Biotechnology
https://jaguar.health
NASDAQ
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for shor...
0001585608
US47010C7065
47010C607
200 Pine Street
415 371 8300
US
60
May 12, 2015
0001585608
NASDAQ
Biotechnology
Healthcare
47010C607
US47010C7065
US
0.08
1.32
37.83M
16.44M
-
0.051-1.22
1.62
-
-
-
-
-0.09
-
https://jaguar.health
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.